Type of jaundice in neonates

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have rich content from multiple authoritative textbooks. Here is a thorough answer:

Types of Jaundice in Neonates

Neonatal jaundice (neonatal hyperbilirubinemia) is classified primarily by the type of bilirubin elevated (unconjugated/indirect vs. conjugated/direct) and then by etiology.

Broad Classification

TypeBilirubinNature
Unconjugated (indirect) hyperbilirubinemiaIndirectUsually benign/physiologic, but can be pathologic
Conjugated (direct) hyperbilirubinemiaDirectAlways pathologic
Three physiologic factors contribute to neonatal unconjugated jaundice: (1) increased bilirubin production, (2) decreased clearance/excretion, and (3) increased enterohepatic resorption. - Rosen's Emergency Medicine

A. Unconjugated (Indirect) Hyperbilirubinemia

1. Physiologic Jaundice of the Newborn

  • Most common type - affects ~50% of normal newborns
  • Due to immature hepatic glucuronosyltransferase + accelerated red cell turnover
  • Onset: Day 2-3 of life (never in the first 24 hours)
  • Peak: Day 4-5 (rarely exceeds 12-15 mg/dL in term infants)
  • Resolution: Within 2 weeks in term infants (longer in preterm)
  • Rises at a rate no more than 5 mg/dL/day
  • Requires no treatment in most cases; phototherapy if rising

2. Breast Milk Jaundice

  • Second most common cause
  • Pathophysiology uncertain - may be hormonally mediated or related to increased enterohepatic resorption, or bilirubin-deconjugating enzymes in breast milk
  • Peaks later than physiologic jaundice (around 10-21 days of life)
  • May persist for 3-10 weeks
  • Mild unconjugated hyperbilirubinemia; generally benign

3. Hemolytic Causes

  • Hemolytic Disease of the Fetus & Newborn (HDFN): ABO or Rh incompatibility - most common cause of severe hyperbilirubinemia
  • Physiologic breakdown of fetal hemoglobin
  • Hemoglobinopathies (e.g., sickle cell)
  • Inherited RBC membrane defects (e.g., hereditary spherocytosis)
  • Enzyme defects (e.g., G6PD deficiency)
  • Sepsis

4. Polycythemia

  • Excess RBC mass leads to increased bilirubin production from hemoglobin breakdown

5. Increased Enterohepatic Circulation

  • Hirschsprung disease, cystic fibrosis, biliary atresia (delayed passage of meconium delays bilirubin excretion)

6. Inherited Disorders of Bilirubin Metabolism

DisorderKey Feature
Gilbert syndromeMildly reduced glucuronosyltransferase; autosomal recessive; benign, fluctuating unconjugated hyperbilirubinemia
Crigler-Najjar Type IComplete absence of UDP-glucuronosyltransferase; severe jaundice >20 mg/dL; fatal in infancy if untreated
Crigler-Najjar Type IIPartial enzyme deficiency; serum bilirubin usually <20 mg/dL; responds to phenobarbital

B. Conjugated (Direct) Hyperbilirubinemia

Conjugated hyperbilirubinemia in neonates is always pathologic. - Rosen's Emergency Medicine
CategorySpecific Causes
Biliary obstructionExtrahepatic biliary atresia (most common surgical cause)
InfectionSepsis, TORCH infections (toxoplasmosis, rubella, CMV, herpes, syphilis)
Neonatal hepatitisIdiopathic, Wilson disease, alpha-1 antitrypsin deficiency
Metabolic disordersGalactosemia, hereditary fructose intolerance, glycogen storage disease
Inherited transport defectsDubin-Johnson syndrome (dark pigmented liver), Rotor syndrome
Parenteral alimentationTPN-associated cholestasis

Key Danger: Kernicterus (Bilirubin Encephalopathy)

When unconjugated bilirubin exceeds the albumin-binding capacity (generally at levels >20-25 mg/dL), it crosses the blood-brain barrier and causes neuronal death - termed kernicterus (chronic) or bilirubin-induced neurologic dysfunction (BIND) (acute).
Acute symptoms: Poor feeding, lethargy, high-pitched cry, opisthotonos, seizures
Chronic sequelae: Cerebral palsy, sensorineural hearing loss, gaze abnormalities, intellectual disability

Risk Factors for Severe Hyperbilirubinemia

  • Prematurity
  • Isoimmune hemolysis (ABO, Rh incompatibility)
  • Sepsis
  • Cephalhematoma
  • Dehydration
  • G6PD deficiency, hereditary spherocytosis

Treatment Approach

  • Phototherapy (blue light): First-line for unconjugated hyperbilirubinemia; converts bilirubin to a water-soluble isomer excreted in urine
  • Phenobarbital: Induces bilirubin metabolism (used in Crigler-Najjar Type II)
  • Exchange transfusion: For severe/refractory cases with rising bilirubin near toxic levels

Sources: Rosen's Emergency Medicine, Robbins & Kumar Basic Pathology, Harper's Illustrated Biochemistry (32nd Ed), Quick Compendium of Clinical Pathology (5th Ed), Medical Physiology
This is a shared conversation. Sign in to Orris to start your own chat.